Ajanta Pharma

BSE : 532331 | NSE : AJANTPHARM

Industry : Pharma Formulations | ISIN : INE031B01049 | FreeFloat : 30.00% | FnO : No | LotSize : N/A


Intellectual Capital (IC)11,856.60
Net Worth (NW)3,603.48
Intrinsic Worth (IW)15,460.08
Market Cap (MC)16,303.28
Economic Value Added46.95
Discount Rate%
Liquidity Premium%
Knowledge Basis (IC/IW)76.69%
IC Gross Margin (EBITDA/IC)8.97%
IC Net Margin (NPT/IC)6.27%
Knowledge Turnover (Sales/IC)0.32
Market to Intrinsic Value (MC/IW)1.05

As OfIntrinsic ValueMarket Price
30 Sep 2022Rs. 1,206.64Rs. 1,272.45
29 Nov 2022 ---- Rs. 1,234.30
-17.20     -1.39%
Fundamental - medium termTechnical - near termCombined outlook
EVA > 0 : YesBuy10 DMA : Rs. 1,243.18SellAvoid
KB > 50% : Yes50 DMA : Rs. 1,265.83
0 < M2IV < 1 : NoVol-Price trend : Falling

Question 3 - Is this stock undervalued?


Question 2 - Does this business have significant knowledge assets?


Question 1 - Is this business generating enough profits to cover its cost of capital?

* EVA is a registered trademark of Stern Stewart and Co.

Quarterly Results (Rs. Cr)
Quarter
Type*
Sales
Income
EBITDA
EBIT
PBT
PAT
NPT
Dec-19
C
651.21
665.85
200.27
176.67
175.10
107.55
109.38
Mar-20
C
681.96
738.65
205.52
179.48
175.86
129.16
134.05
Jun-20
C
668.20
681.32
236.34
208.32
206.69
147.76
148.54
Sep-20
C
715.91
720.76
279.10
250.77
249.24
170.22
166.36
Dec-20
C
748.74
754.22
247.16
218.02
215.47
176.63
176.77
Mar-21
C
756.84
759.37
261.94
231.34
228.78
159.26
156.44
Jun-21
C
747.99
780.62
252.84
221.96
220.45
173.75
171.75
Sep-21
C
884.80
914.34
292.36
260.82
260.42
195.94
195.29
Dec-21
C
837.91
861.94
263.61
231.89
230.94
191.78
190.19
Mar-22
C
870.29
899.77
236.17
205.01
197.67
151.21
150.41
Jun-22
C
950.93
983.69
254.52
222.74
221.86
174.62
179.82
Sep-22
C
938.10
978.45
236.69
203.99
203.00
156.60
159.26
* C - Consolidated, S - Standalone